Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular...

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Reactive oxygen species (ROS) play a dual role in cancer, promoting oncogenesis while also inducing apoptosis in malignant cells.
• Extracellular superoxide anions from NADPH oxidase 1 (NOX1) are key in maintaining the transformed state.
• Tumor progression leads to resistance against ROS-induced apoptosis, often mediated by membrane-associated catalase.

Purpose of the Study:

• To investigate novel therapeutic strategies targeting catalase-mediated resistance to ROS-induced apoptosis in cancer cells.
• To explore the translation of in vitro findings on ROS-dependent signaling into in vivo experimental therapies.

Main Methods:

• In vitro development of approaches involving antibody-mediated catalase inhibition.
• Utilizing ROS-driven singlet oxygen generation to inactivate tumor cell catalase.
• Leveraging malignant cell-generated superoxide anions to induce selective apoptosis.

Main Results:

• Demonstrated that membrane-associated catalase confers resistance to ROS-induced apoptosis in tumor cells.
• Developed in vitro methods to overcome catalase-mediated resistance.
• Showcased the potential for selective induction of apoptosis in malignant cells via ROS signaling.

Conclusions:

• Membrane-associated catalase is a unique and promising target for cancer therapy.
• Targeting ROS-dependent signaling pathways offers a selective approach to eliminate malignant cells.
• The study proposes translating these findings for in vivo experimental cancer therapy.